Brief: Quidelortho Receives 510(K) Clearance For Savanna® Multiplex Molecular Platform And Savanna® Hsv 1+2/Vzv Pcr Assay
Dec 20 (Reuters) - Quidelortho Corp QDEL.O :
* QUIDELORTHO RECEIVES 510(K) CLEARANCE FOR SAVANNA®
MULTIPLEX
MOLECULAR PLATFORM AND SAVANNA® HSV 1+2/VZV PCR ASSAY
* QUIDELORTHO CORP - SAVANNA WILL BE AVAILABLE TO
PROFESSIONAL
CUSTOMERS ON DECEMBER 20, 2023
Source text for Eikon: ID:nBw3vBjKMa
Further company coverage: QDEL.O
((Reuters.Briefs@thomsonreuters.com;))